Dose reduction and discontinuation of alendronate in postmenopausal osteoporotic women who were receiving estrogen therapy
Stefano Palomba, Francesco Orio Jr., Tiziana Russo, Annamaria Colao, Gaetano Lombardi, Fulvio ZulloVolume:
81
Year:
2004
Language:
english
DOI:
10.1016/j.fertnstert.2003.07.017
File:
PDF, 47 KB
english, 2004